T. Rowe Price Associates’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $11.9M | Sell |
|
|||||
|
2019
Q2 | $90.6M | Sell |
|
|||||
|
2019
Q1 | $124M | Buy |
|
|||||
|
2018
Q4 | $79M | Buy |
|
|||||
|
2018
Q3 | $120M | Buy |
|
|||||
|
2018
Q2 | $29.4M | Buy |
|
|||||
|
2018
Q1 | $13.8M | Buy |
|
|||||
|
2017
Q4 | $12.4M | Buy |
|
|||||
|
2017
Q3 | $11.7M | Sell |
|
|||||
|
2017
Q2 | $11.3M | Buy |
|
|||||
|
2017
Q1 | $8.7M | Sell |
|
|||||
|
2016
Q4 | $9.06M | Buy |
|
|||||
|
2016
Q3 | $9.52M | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $2.19M | Sell |
|
|||||
|
2015
Q4 | $4.05M | Buy |
|
|||||
|
2015
Q3 | $4.02M | Buy |
|
|||||
|
2015
Q2 | $2.28M | Buy |
|